Literature DB >> 33947402

Systematic review and policy dialogue to determine challenges in evidence-informed health policy-making: findings of the SASHA study.

Bahareh Yazdizadeh1, Haniye Sadat Sajadi2, Farideh Mohtasham1, Mahsa Mohseni1, Reza Majdzadeh3.   

Abstract

BACKGROUND: Various interventions have been undertaken in Iran to promote evidence-informed health policy-making (EIHP). Identifying the challenges in EIHP is the first step toward strengthening EIHP in each country through the design of tailored interventions. Therefore, the current study was conducted to synthesize the results of earlier studies and to finalize the list of barriers to EIHP in Iran.
METHODS: To identify the barriers to EIHP in Iran, two steps were taken: a systematic review and policy dialogue. To conduct the systematic review, three Iranian databases and PubMed, Health Systems Evidence (HSE), Embase, and Scopus were searched. The reference lists of included papers and documentation from some local organizations were hand-searched. Upon conducting the systematic review, given the significance of stakeholders in clarifying the problem of EIHP, policy dialogue was used to complete the list previously extracted and to do advocacy. Selection criteria for the stakeholders included influential and informed individuals from knowledge-producing, knowledge-utilizing, and knowledge-brokering organizations. Semi-structured interviews were held with three important absent stakeholders.
RESULTS: Challenges specific to Iran that were identified included the lack of integration of the health ministry and the medical universities, lack of ties between health knowledge utilization organizations, failure to establish long-term research plans, neglect of national research needs at the time of recruiting human resources in knowledge-producing organizations, and duplication and lack of coordination in routine data obtained from surveillance systems, disease registration systems, and censuses. It seems that some challenges are common across countries, including neglecting the importance of inter- and intra-disciplinary studies, the capacity of policy-makers and managers to utilize evidence, the criteria for evaluating the performance of policy-makers, managers, and academic members, the absence of long-term programmes in knowledge-utilizing organizations, the rapid replacement of policy-makers and managers, and lack of use of evaluation studies.
CONCLUSIONS: In this study, we tried to identify the challenges regarding EIHP in Iran using a systematic review and policy dialogue approach. This is the first step toward determining the best interventions to improve evidence-informed policy-making in each country, because these challenges are contextual and need to be investigated contextually.

Entities:  

Keywords:  Evidence utilization; Evidence-informed policy-making; Health policy-making

Year:  2021        PMID: 33947402     DOI: 10.1186/s12961-021-00717-x

Source DB:  PubMed          Journal:  Health Res Policy Syst        ISSN: 1478-4505


  27 in total

1.  Evidence-based health policy: context and utilisation.

Authors:  Mark J Dobrow; Vivek Goel; R E G Upshur
Journal:  Soc Sci Med       Date:  2004-01       Impact factor: 4.634

2.  Use of evidence in WHO recommendations.

Authors:  Andrew D Oxman; John N Lavis; Atle Fretheim
Journal:  Lancet       Date:  2007-06-02       Impact factor: 79.321

Review 3.  A systematic review of barriers to and facilitators of the use of evidence by policymakers.

Authors:  Kathryn Oliver; Simon Innvar; Theo Lorenc; Jenny Woodman; James Thomas
Journal:  BMC Health Serv Res       Date:  2014-01-03       Impact factor: 2.655

Review 4.  Political and institutional influences on the use of evidence in public health policy. A systematic review.

Authors:  Marco Liverani; Benjamin Hawkins; Justin O Parkhurst
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

5.  Health technology assessment in Iran: challenges and views.

Authors:  Alireza Olyaeemanesh; Shila Doaee; Mohammadreza Mobinizadeh; Mina Nedjati; Parisa Aboee; Seyed Hassan Emami-Razavi
Journal:  Med J Islam Repub Iran       Date:  2014-12-29

6.  A roadmap for strengthening evidence-informed health policy-making in Iran: protocol for a research programme.

Authors:  Haniye Sadat Sajadi; Reza Majdzadeh; Bahareh Yazdizadeh; Farideh Mohtasham; Mahsa Mohseni; Leila Doshmangir; John Lavis
Journal:  Health Res Policy Syst       Date:  2019-05-17

7.  SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking.

Authors:  John N Lavis; Jennifer A Boyko; Andrew D Oxman; Simon Lewin; Atle Fretheim
Journal:  Health Res Policy Syst       Date:  2009-12-16

Review 8.  Evidence for Health II: Overcoming barriers to using evidence in policy and practice.

Authors:  Anne Andermann; Tikki Pang; John N Newton; Adrian Davis; Ulysses Panisset
Journal:  Health Res Policy Syst       Date:  2016-03-14

9.  An assessment of health research impact in Iran.

Authors:  Bahareh Yazdizadeh; Reza Majdzadeh; Leila Janani; Farideh Mohtasham; Sima Nikooee; Abdmohammad Mousavi; Farid Najafi; Maryam Atabakzadeh; Azam Bazrafshan; Morteza Zare; Manoochehr Karami
Journal:  Health Res Policy Syst       Date:  2016-07-26

10.  Impact assessment of Iran's health technology assessment programme.

Authors:  Bahareh Yazdizadeh; Farideh Mohtasham; Ashraf Velayati
Journal:  Health Res Policy Syst       Date:  2018-02-22
View more
  1 in total

1.  Policy options for strengthening evidence-informed health policy-making in Iran: overall SASHA project findings.

Authors:  Reza Majdzadeh; Haniye Sadat Sajadi; Bahareh Yazdizadeh; Leila Doshmangir; Elham Ehsani-Chimeh; Mahdi Mahdavi; Neda Mehrdad; John Lavis; Sima Nikooee; Farideh Mohtasham; Mahsa Mohseni; Paria Akbari; Mohammad Hossein Asgardoon; Niloofar Rezaei; Narges Neyazi; Saeideh Ghaffarifar; Ali Akbar Haghdoost; Rahim Khodayari-Zarnaq; Ali Mohammad Mosadeghrad; Ata Pourabbasi; Javad Rafinejad; Reza Toyserkanamanesh
Journal:  Health Res Policy Syst       Date:  2022-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.